Latest Trends and Opportunities in Aptamer Market (2017 - 2025)
According to a new report published by Reports Monitor titled, “ Global Aptamer Market, Growth Opportunities, Innovations and Forecast, 2018-2025,” the global aptamer market was valued at XX million in 2018, and is projected to reach at XX million by 2025, growing at a CAGR of XX% from 2018 to 2025.
In the field of life science, aptamers plays a important role and are majorly researched for application such as therapeutic agents, analytical tools and as vehicles for targeted drug delivery. Aptamers have attracted the attention of many scientists, because have all of the advantages of antibodies and also have unique merits such as low cost, thermal stability and many more unlimited applications, aptamers are evolving at an exponential rate gaining from the newest advances in nanotechnology, chemistry, biology and medicine due of their synthetic nature.
Research and development investments in pharmaceutical and biotechnology industries, technological advancements, low cost and high efficiency of aptamers in binding to large molecules as compared to antibodies are driving the growth of the aptamers market and the patent expiration of systematic evolution of ligands by exponential enrichment technology (SELEX). Many aptamers have failed to meet the requisite efficacy and safety standards in clinical studies. Hence, companies have to end up their clinical investigation during late-stage clinical studies. This factor is affecting the growth of this market negatively. Additionally, other factors such as inadequate regulatory structure and low awareness about these technologies in middle- & low-income countries and, may hamper the overall growth.
The global aptamer market research report provides key insights on the growth opportunities of this market based on applications, types, end user, technology and regions. It includes detailed analysis of the current market situations such as market size, upcoming developments and investments. The increasing applications of aptamers in chemical and food industries are expected to create huge opportunities for market growth. Moreover, nucleic acid aptamers offer potential antagonist actions against various disease-associated proteins, are low in toxicity, and also provide high affinity ligands. By application, the therapeutics development segment is expected to lead by 2019. The characteristics of aptamers such as high stability and low toxicity as well as safety are increasingly drawing the attention of many biotechnology and pharmaceutical companies. Aptamers can be modified to boost their therapeutic abilities and also to increase their life. The modification of the chemical structure of aptamers can also improve their nuclease resistance. Manufacturers can optimize the pharmacokinetic and pharmacodynamics properties of aptamers for better in vivo applications. Therefore focusing on altering the structure of aptamers will create new opportunities for manufacturers and help them earn more revenues.
The global aptamer market is analyzed across segments such as on the basis of type, the nucleic acid aptamers segment is expected to lead owing to their distinct ability to selectively inhibit protein targets more specifically. Aptamers are segmented on the basis of types including Nucleic Acid aptamers, DNA-Based aptamers, RNA-Based aptamers, XNA-Based aptamers ,Peptide aptamers. On the basis of applications covering research and development, diagnostics, therapeutics development. On the basis of end users such as bio-pharmaceutical companies, contract research organization, pharmaceutical companies, academic and research centers. Additionally it is also segmented on the basis of technology like SELEX and concluding, the segmentation is done on the basis of regions covering Asia Pacific (China, India, ASEAN, Australia & New Zealand), North America (U.S., Canada), Latin America (Mexico, Brazil and Rest of Latin America), Eastern Europe (Poland, Russia and Rest of Eastern Europe) and Middle East and Africa (GCC, S. Africa, and Rest of MEA).
Aptamers market is classified into regions like Middle east and Africa, North Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, North America, Japan. Whereas, Europe and North America will remain key markets for aptamers market. Asia Pacific is anticipated to register positive growth owing to increased opportunities in diagnostics and development of pharmaceuticals which are remain untapped in the aptamers market. Owing to presence of key players in the market, Europe region is expected to witness strong growth.
The key vendors in this market are:
AM Biotechnologies LLC, Aptagen LLC, Aptamer Sciences Inc, TriLink BioTechnologies Inc, Aptamer Solutions Ltd, Base Pair Biotechnologies Inc, Aptus Biotech S.L, SomaLogic Inc.
About Garner Insights:
We at Garner Insights.com provide a comprehensive analysis by providing in-depth reports of the various market verticals. Our Mission is to provide a detailed analysis of the vast markets worldwide backed by rich data. Decision makers can now rely on our well-defined data gathering methods to get the correct and accurate market forecasting along with detailed analysis.